FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy Read more
CureVac Receives U.S. Patent Covering Entire Process for Pharmaceutical Manufacturing of RNA Read more
vTv Therapeutics Announces Completion of Phase 1b Study Evaluating TTP399 for the Treatment of Type 1 Diabetes Read more
Aldevron Selects AES, Begins Construction of Cleanrooms in $30 Million GMP Plasmid Facility Read more
Invitation from ZivaAbarahm, CEO at Microrite chairing The 2nd Annual Pharmaceutical Microbiology West Coast Conference 2018 Read more